Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ProLife Medica Sp. z O.O. ETG Poniatowa

Verified siteinfo

Poland Ul. Fabryczna 18, 24-320 Poniatowa, Poland

  • Arteriosclerosis · Cardiovascular disorder · Chronic kidney disease
  • Adult patients

About Specializations

ProLife Medica Sp. z O.O. ETG Poniatowa in Poniatowa, Poland specialises in clinical trials of conditions such as Arteriosclerosis, Cardiovascular disorder, Chronic kidney disease, Hyperlipidaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Health and Lipid Management

The medical center is at the forefront of research in cardiovascular health, with a particular focus on managing hyperlipidaemia. This condition, characterized by elevated levels of lipids in the blood, is a significant risk factor for cardiovascular diseases.

  • LDL-C Reduction Strategies
  • High-Intensity Statin Therapy
  • Combination Lipid-Lowering Treatments

Through its research, the center is advancing the understanding of effective lipid management strategies, including the use of high-intensity rosuvastatin and combination therapies like rosuvastatin/ezetimibe. These efforts aim to achieve optimal LDL-C levels in patients at high or very high risk of cardiovascular disease, thereby improving patient outcomes and reducing the incidence of cardiovascular events.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Fabryczna 1824-320 PoniatowaPoland
Open in maps ↗
Recruiting now
no trials
Conditions studied
5
Partner status
Verified site

More sites in PoniatowaPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Rheumatoid arthritis

Not yet recruiting

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Cardiovascular disorder

Not recruiting

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Hyperlipidaemia

Not recruiting

Study on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:KRKA tovarna zdravil d.d. Novo mesto
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.